![First drug developed by generative AI administered to patients](https://dailytalks.org/wp-content/uploads/2023/08/89627-first-drug-developed-by-generative-ai-administered-to-patients.jpg)
Insilico Medicine, a biotechnology company based in Hong Kong, announced that human patients have begun receiving the drug INS018_055, an anti-fibrotic small molecule inhibitor…
Read More
Your trusted source of news.
Insilico Medicine, a biotechnology company based in Hong Kong, announced that human patients have begun receiving the drug INS018_055, an anti-fibrotic small molecule inhibitor…
Read More